Image 1 (F0441ca2 31d9 4d0f 9d12 Be68c9d39666 01)
Sildenafil Powder, For Suspension
Product Images NDC 68180-283
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 22 technical images submitted to the FDA as part of the official labeling for Sildenafil (NDC 68180-283). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Lupin Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Image 2 (F0441ca2 31d9 4d0f 9d12 Be68c9d39666 02)
Image 3 (F0441ca2 31d9 4d0f 9d12 Be68c9d39666 03)
Image 4 (F0441ca2 31d9 4d0f 9d12 Be68c9d39666 04)
Image 5 (F0441ca2 31d9 4d0f 9d12 Be68c9d39666 05)
Image 6 (F0441ca2 31d9 4d0f 9d12 Be68c9d39666 06)
Image (F0441ca2 31d9 4d0f 9d12 Be68c9d39666 07)
This is not-available. The provided text is not enough to give any useful description as it contains symbols only.*
Image 7 (F0441ca2 31d9 4d0f 9d12 Be68c9d39666 08)
This is a table that provides recommendations for adjusting doses of specific drugs when combined with other medications. Atorvastatin may need to be adjusted, while oral contraceptives do not. The column on the right provides information on how the drugs perform relative to using Sidenatil alone. An additional comment states that adding Sidenatil to bosentan therapy provides no exercise capacity benefits.*
Image 8 (F0441ca2 31d9 4d0f 9d12 Be68c9d39666 09)
This text appears to be a table showing the interaction of various drugs with different dosages and their effect on other drugs. It includes recommendations for dose adjustments where required and notes when no adjustment is needed. The text also mentions the measurement of INR Cmax and AUC for Tolbutamide. There is also a mention of the effect of fonavic on sildenafil PK. It is unclear what the context of this information is without further information.*
Image 9 (F0441ca2 31d9 4d0f 9d12 Be68c9d39666 10)
Figure 10 (F0441ca2 31d9 4d0f 9d12 Be68c9d39666 11)
This is a summary of a clinical study on the effects of a medication called Sildenafil for patients with Pulmonary Arterial Hypertension (PAH). The study measured the ability of patients to walk a certain distance before and after taking the medication, as well as their mean pulmonary arterial pressure. The results are shown in a graph that compares the change in walking distance between patients who took the medication and those who received a placebo.*
Image 11 (F0441ca2 31d9 4d0f 9d12 Be68c9d39666 12)
Image 12 (F0441ca2 31d9 4d0f 9d12 Be68c9d39666 13)
Image 13 (F0441ca2 31d9 4d0f 9d12 Be68c9d39666 14)
Image 14 (F0441ca2 31d9 4d0f 9d12 Be68c9d39666 15)
Image 15 (F0441ca2 31d9 4d0f 9d12 Be68c9d39666 16)
Image 16 (F0441ca2 31d9 4d0f 9d12 Be68c9d39666 17)
Image 17 (F0441ca2 31d9 4d0f 9d12 Be68c9d39666 18)
Image 18 (F0441ca2 31d9 4d0f 9d12 Be68c9d39666 19)
Image 19 (F0441ca2 31d9 4d0f 9d12 Be68c9d39666 20)
Image 20 (F0441ca2 31d9 4d0f 9d12 Be68c9d39666 21)
This is a description of a prescription drug called Sildenafil from Lupin Pharmacy. It is a grape-flavored oral suspension that contains 10mg/mL of Sildenafil in a 112mL bottle. It needs to be shaken well before use, and each mL contains 10mg of Sildenafil. The drug needs to be stored below 30°C before and after reconstitution. The reconstituted drug needs to be refrigerated and should not be frozen. Any unused portion should be discarded after 60 days. The recommended dosage is not available, and the text includes information about the drug's manufacturer and code.*
Image 21 (F0441ca2 31d9 4d0f 9d12 Be68c9d39666 22)
Sildenafil for oral suspension is a medication that must be shaken well before usage. It comes in grape flavor and has a recommended dosage mentioned in the prescribing information. The powder for oral suspension should be stored below 30°C. The instructions for reconstitution are provided on the bottle. The medication is manufactured by Lupin Pharmaceuticals and should be used within 60 days after reconstitution. An oral dosing syringe and a press-in bottle adaptor are also provided.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
